我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

氯吡格雷无反应：从基因到临床(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2011年第5期
页码:
664-666
栏目:
综述
出版日期:
2011-10-25

文章信息/Info

Title:
-
作者:
赵树梅 综述; 李虹伟 审阅
首都医科大学附属北京友谊医院心血管中心，北京 100050
Author(s):
-
关键词:
氯吡格雷无反应; 基因因素; 细胞因素; 临床因素
Keywords:
-
分类号:
R973
DOI:
-
文献标识码:
A
摘要:
数年前人们提出“氯吡格雷无反应”的现象，本文就近几年不断累积的临床和基础研究提出了新的认识和理解。
Abstract:
-

参考文献/References

[1]白艳艳,王长谦.氯吡格雷抵抗研究进展[J].心脏杂志,2007.19(1):96-98.

[2]刘 普,马依彤.支架内血栓形成的原因及防治[J].心脏杂志,2008,20(1):108-110.

[3]Combescure C,Fontana P,Mallouk N,et al.Clinical implications of clopidogrel non-response in cardiovascular patients:a systematic review and meta-analysis[J].J Thromb Haemost,2010,8(5):923-933.

[4]Bhatt DL,Scheiman J,Abraham NS, et al.ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use:a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents[J].J Am Coll Cardiol,2008,52(18):1502-1517.

[5]Ho PM,Maddox TM,Wang L,et al.Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome[J].JAMA,2009,301(9):937-944.

[6]Gilard M,Arnaud B,Cornily JC,et al.Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin:the randomized,double-blind OCLA (Omeprazole CLopidogrel Aspirin) study[J].JACC,2008,51(3): 256-260.

[7]Juurlink DN,Gomes T,Ko DT,et al.A population-based study of the drug interaction between proton pump inhibitors and clopidogrel[J].CMAJ,2009,180(7):713-718.

[8]Bhatt DL,Cryer BL,Contant CF,et al.Clopidogrel with or without omeprazole in coronary artery disease[J].N Engl J Med,2010,363(20):1909-1917.

[9]Abraham NS,Hlatky MA,Antman EM,et al.ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines:a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use[J].J Am Coll Cardiol,2010,56(24):2051-2066.

[10]Saw J,Brennan DM,Steinhubl SR,et al.Lack of evidence of a clopidogre statin interaction in the CHARISMA trial[J].J Am Coll Cardiol, 2007,50(4):291-295.

[11]Mangiacapra F,Muller O,Ntalianis A,et al.Comparison of 600 versus 300-mg Clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary coronary angioplasty[J].Am J Cardiol,2010,106(9):1208-1211.

[12]CURRENT-OASIS 7 Investigators, Mehta SR,Bassand JP,et al.Dose comparisons of clopidogrel and aspirin in acute coronary syndromes[J].N Engl J Med,2010,363(10):930-942.

[13]Angiolillo1 DJ,Capodanno D,Goto S.Platelet thrombin receptor antagonism and atherothrombosis[J].European Heart Journal,2010,31(1):17-28.

[14]Wiviott SD,Braunwald E,McCabe CH,et al.Prasugrel versus clopidogrel in patients with acute coronary syndromes[J].N Engl J Med,2007,357(20):2001-2015.

[15]Wallentin L,Becker RC,Budaj A,et al.Ticagrelor versus clopidogrel in patients with acute coronary syndromes[J].N Engl J Med,2009,361(11):1045-1057.

备注/Memo

备注/Memo:
收稿日期：2011-01-16.通讯作者：李虹伟，主任医师，主要从事心血管疾病及代谢综合 征防治的研究Email：mcw19656@yahoo.com.cn 作者简介：赵树梅，副主任医师，博士Email：yd678182@163.com
更新日期/Last Update: 2011-11-03